Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent anticancer cytotoxic agents.

Paolo Cozzi1, Nicola Mongelli, Antonino Suarato

  • 1Pharmacia Italia, Gruppo Pfizer Inc, Discovery Research Oncology, Department of Chemistry, Viale Pasteur 10, 20014 Nerviano, Milan, Italy. paolo.cozzi@pharmacia.com

Current Medicinal Chemistry. Anti-Cancer Agents
|March 23, 2004
PubMed
Summary
This summary is machine-generated.

Cytotoxic chemotherapy drugs, derived from natural sources, remain crucial for cancer treatment. Research focuses on new natural and synthetic agents, including tubulin stabilizers and DNA interactive compounds, for future cancer therapy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic insights into Greek sheep structure and admixture with global domestic breeds.

BMC genomics·2026
Same author

Exploring Genomic Variability in the Mediterranean Buffalo Breed: A Step Towards Custom SNP Array.

Animals : an open access journal from MDPI·2026
Same author

Design and Comparative Numerical Analysis of AlSi10Mg PBF-LB/M Manufactured TPMS Lattice Structures for Improved Mechanical Performance.

Materials (Basel, Switzerland)·2025
Same author

Estimating the optimal number of samples to determine the effective population size in livestock.

Frontiers in genetics·2025
Same author

Exploring the complex population structure and admixture of four local Hungarian sheep breeds.

Frontiers in genetics·2025
Same author

Defining bovine CpG epigenetic diversity by analyzing RRBS data from sperm of Montbéliarde and Holstein bulls.

Frontiers in cell and developmental biology·2025
Same journal

Selenium derivatives as cancer preventive agents.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Lycopene: a review of its potential as an anticancer agent.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Sulfo-quinovosyl-acyl-glycerol (SQAG), a eukaryotic DNA polymerase inhibitor and anti-cancer agent.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Current drug therapy for prostate cancer: an overview.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Lanthanides as anticancer agents.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy.

Current medicinal chemistry. Anti-cancer agents·2005
See all related articles

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Oncology

Background:

  • Despite advances in cancer diagnosis and treatment, high mortality persists, indicating an unmet medical need.
  • Innovative strategies targeting tumor cells and angiogenesis are under development but require further evaluation.
  • Cytotoxic drugs, often derived from natural products, will remain central to cancer therapy, potentially combined with novel targeted agents.

Purpose of the Study:

  • To review the medicinal chemistry and development status of anticancer cytotoxic agents.
  • To highlight the ongoing importance of natural product-derived and synthetic cytotoxic drugs in oncology.
  • To discuss the future contributions of tubulin stabilizers and DNA-interactive agents.

Main Methods:

  • Literature review of medicinal chemistry and drug development in oncology.
  • Analysis of traditional and investigational cytotoxic anticancer agents.
  • Focus on natural product derivatives, synthetic modifications, and novel mechanisms of action.

Main Results:

  • Natural products have historically yielded significant anticancer drugs like taxanes and camptothecins.
  • Anthracyclines and DNA minor groove binders are key examples of DNA-interacting agents.
  • New natural and semi-synthetic agents targeting tubulin and DNA are under active investigation.

Conclusions:

  • Cytotoxic agents, particularly those derived from natural sources or synthetically modified, continue to be vital in cancer treatment.
  • Future cancer therapy will likely involve combinations of established cytotoxic drugs with innovative targeted agents.
  • Ongoing research into novel tubulin stabilizers and DNA-interactive compounds promises significant contributions to oncology.